T

TM3 Therapeutics

1 employees

Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
cancer
metabolic disease
Wellness
biotechnology
Health Care
CoEnzyme A
rare disease

Date founded

2018

Funding rounds raised

Total raised

$29M

from 4 investors over 4 rounds

T

TM3 Therapeutics raised $29M on June 19, 2019

Investors: Inkef, Sofinnova Partners, Canaan and Mission BioCapital

FAQ